Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
about
Exogenous asymmetric dimethylarginine (ADMA) in pathogenesis of ischemia-reperfusion-induced gastric lesions: interaction with protective nitric oxide (NO) and calcitonin gene-related peptide (CGRP).A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling.Protective effect of Pu-erh tea extracts against ethanol-induced gastric mucosal damage in rats.
P2860
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@en
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@nl
type
label
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@en
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@nl
prefLabel
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@en
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@nl
P2093
P2860
P356
P1476
Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?
@en
P2093
Chang-Ping Hu
Yi-You Zou
P2860
P304
P356
10.3748/WJG.V17.I17.2178
P407
P577
2011-05-01T00:00:00Z